Galectin Therapeutics makes presentation after Annual Meeting on December 1, 2022

GALECTIN THERAPEUTICS INC

Company held Annual Meeting of Stockholders virtually due to Covid-19 precautions.
Management and Board presented after the meeting; transcript attached as Exhibit 99.1.
Presentation included forward-looking statements with standard cautionary language.
Transcript filed with SEC on December 1, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.